Read Time: 9 min read Ozempic and other glucagon-like peptide inhibitors (GLP-1s) have taken the world by storm
Most patients begin to notice some weight loss within the first month of starting semaglutide GLP-1 treatment
Mild diarrhea, upset stomach, nausea, a feeling of pain and a warm sensation at the site of the injection, a feeling, or a sense, of being swollen over the entire body, flushing, headache, skin rashes, and joint pain
it does not support a clinical recommendation, including for athletes with tendon injuries
Most gastrointestinal side effects are mild to moderate and tend to resolve on their own as your body builds a tolerance
Glucose sensing mediated by portal glucagon-like Peptide 1 receptor is markedly impaired in insulin-resistant obese animals